PubMed

Skeletal lead release during bone resorption: effect of bisphosphonate treatment in a pilot study.

Gulson B, Mizon K, Smith H, Eisman J, Palmer J, Korsch M, Donnelly J, Waite K.

Environ Health Perspect. 2002 Oct;110(10):1017-23.PMID: 12361927 [PubMed - indexed for MEDLINE]Related articlesFree article

New bone drug benefit. Less skeletal lead released.

Hood E.

Environ Health Perspect. 2002 Oct;110(10):A591. No abstract available. PMID: 12378704 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of osteoporosis medications on bone quality.

Benhamou CL.

Joint Bone Spine. 2007 Jan;74(1):39-47. Epub 2006 Nov 28. Review.PMID: 17196423 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.

Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR; FLEX Research Group.

JAMA. 2006 Dec 27;296(24):2927-38.PMID: 17190893 [PubMed - indexed for MEDLINE]Related articlesFree article

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial.

Bauer DC, Garnero P, Hochberg MC, Santora A, Delmas P, Ewing SK, Black DM; for the Fracture Intervention Research Group.

J Bone Miner Res. 2006 Feb;21(2):292-9. Epub 2005 Oct 31.PMID: 16418785 [PubMed - indexed for MEDLINE]Related articles

Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients.

Iizuka T, Matsukawa M.

Climacteric. 2008 Aug;11(4):287-95.PMID: 18645694 [PubMed - indexed for MEDLINE]Related articles

Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.

Gur A, Colpan L, Cevik R, Nas K, Jale Sarac A.

Clin Biochem. 2005 Jan;38(1):66-72.PMID: 15607319 [PubMed - indexed for MEDLINE]Related articles

Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.

Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G, Carella C.

J Bone Miner Res. 2005 Mar;20(3):480-6. Epub 2004 Nov 29.PMID: 15746993 [PubMed - indexed for MEDLINE]Related articles

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ; PaTH Study Investigators.

N Engl J Med. 2003 Sep 25;349(13):1207-15. Epub 2003 Sep 20.PMID: 14500804 [PubMed - indexed for MEDLINE]Related articlesFree article

Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD.

Lewiecki EM, Miller PD, McClung MR, Cohen SB, Bolognese MA, Liu Y, Wang A, Siddhanti S, Fitzpatrick LA; AMG 162 Bone Loss Study Group.

J Bone Miner Res. 2007 Dec;22(12):1832-41.PMID: 17708711 [PubMed - indexed for MEDLINE]Related articles

Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.

Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.

Clin Endocrinol (Oxf). 2004 May;60(5):568-75.PMID: 15104559 [PubMed - indexed for MEDLINE]Related articles

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

Seibel MJ, Naganathan V, Barton I, Grauer A.

J Bone Miner Res. 2004 Feb;19(2):323-9. Epub 2003 Dec 16.PMID: 14969403 [PubMed - indexed for MEDLINE]Related articles

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.

Rosen CJ, Hochberg MC, Bonnick SL, McClung M, Miller P, Broy S, Kagan R, Chen E, Petruschke RA, Thompson DE, de Papp AE; Fosamax Actonel Comparison Trial Investigators.

J Bone Miner Res. 2005 Jan;20(1):141-51. Epub 2004 Sep 29.PMID: 15619680 [PubMed - indexed for MEDLINE]Related articles

Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study.

Katayama K, Matsuno T.

Clin Drug Investig. 2008;28(3):149-58.PMID: 18266400 [PubMed - indexed for MEDLINE]Related articles

Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.

Kim SW, Park DJ, Park KS, Kim SY, Cho BY, Lee HK, Shin CS.

Endocr J. 2005 Dec;52(6):667-74.PMID: 16410657 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis.

Chailurkit LO, Jongjaroenprasert W, Rungbunnapun S, Ongphiphadhanakul B, Sae-tung S, Rajatanavin R.

J Bone Miner Metab. 2003;21(6):421-7.PMID: 14586800 [PubMed - indexed for MEDLINE]Related articles

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J.

Health Technol Assess. 2005 Jun;9(22):1-160. Review.PMID: 15929857 [PubMed - indexed for MEDLINE]Related articlesFree article

Mobilization of lead from human bone tissue during pregnancy and lactation--a summary of long-term research.

Gulson BL, Mizon KJ, Korsch MJ, Palmer JM, Donnelly JB.

Sci Total Environ. 2003 Feb 15;303(1-2):79-104.PMID: 12568766 [PubMed - indexed for MEDLINE]Related articles

Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.

Arlot M, Meunier PJ, Boivin G, Haddock L, Tamayo J, Correa-Rotter R, Jasqui S, Donley DW, Dalsky GP, Martin JS, Eriksen EF.

J Bone Miner Res. 2005 Jul;20(7):1244-53. Epub 2005 Mar 14.PMID: 15940379 [PubMed - indexed for MEDLINE]Related articles